HomeNGNE • NASDAQ
add
Neurogene Inc
Previous close
$21.49
Day range
$19.27 - $20.85
Year range
$14.48 - $74.49
Market cap
290.86M USD
Avg Volume
362.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.90M | 63.16% |
Net income | -20.22M | -38.69% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -21.37M | -48.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 138.99M | 205.06% |
Total assets | 164.12M | 121.75% |
Total liabilities | 26.71M | 107.76% |
Total equity | 137.41M | — |
Shares outstanding | 14.85M | — |
Price to book | 2.04 | — |
Return on assets | -32.24% | — |
Return on capital | -34.73% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -20.22M | -38.69% |
Cash from operations | -15.56M | -34.54% |
Cash from investing | -28.97M | -35,224.39% |
Cash from financing | 131.00K | 107.14% |
Net change in cash | -44.40M | -229.22% |
Free cash flow | -7.53M | -24.09% |
About
Founded
2018
Website
Employees
91
